Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Qian

Showing results (341-350 of 360) with videos related to

Pageof 36
Sort By:
Nature Genetics|January 21, 2026
Multi-trait and multi-ancestry genetic analysis of comorbid lung diseases and traits improves genetic discovery and polygenic risk predictionYixuan He, Wenhan Lu, Yon Ho Jee, et al.
Head & Neck|December 22, 2022
Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilitiesJames R Janopaul-Naylor, Manali Rupji, Rachel A Tobillo, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2022
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral BloodDavid C Qian, Bryan C Ulrich, Gang Peng, et al.
Nature Microbiology|August 31, 2016
The abundant marine bacterium Pelagibacter simultaneously catabolizes dimethylsulfoniopropionate to the gases dimethyl sulfide and methanethiolJing Sun, Jonathan D Todd, J Cameron Thrash, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2009
Discovery and characterization of the N-phenyl-N'-naphthylurea class of p38 kinase inhibitorsPier F Cirillo, Eugene R Hickey, Neil Moss, et al.
Journal of Medicinal Chemistry|October 16, 2004
Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazol-2-one derivativesJiang-Ping Wu, Jonathan Emeigh, Donghong A Gao, et al.
Molecular Carcinogenesis|October 27, 2017
Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancerYun Feng, Yanru Wang, Hongliang Liu, et al.
Journal of Medicinal Chemistry|July 31, 2007
Discovery and optimization of p38 inhibitors via computer-assisted drug designDaniel R Goldberg, Ming-Hong Hao, Kevin C Qian, et al.
Human Molecular Genetics|October 21, 2015
Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactionsDavid C Qian, Jinyoung Byun, Younghun Han, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2021
Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck CancerCanhua Xiao, Andrew H Miller, Gang Peng, et al.
Pageof 36

Showing results (341-350 of 360) with videos related to

Sort By:
Pageof 36
Nature Genetics|January 21, 2026
Multi-trait and multi-ancestry genetic analysis of comorbid lung diseases and traits improves genetic discovery and polygenic risk predictionYixuan He, Wenhan Lu, Yon Ho Jee, et al.
Head & Neck|December 22, 2022
Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilitiesJames R Janopaul-Naylor, Manali Rupji, Rachel A Tobillo, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2022
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral BloodDavid C Qian, Bryan C Ulrich, Gang Peng, et al.
Nature Microbiology|August 31, 2016
The abundant marine bacterium Pelagibacter simultaneously catabolizes dimethylsulfoniopropionate to the gases dimethyl sulfide and methanethiolJing Sun, Jonathan D Todd, J Cameron Thrash, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2009
Discovery and characterization of the N-phenyl-N'-naphthylurea class of p38 kinase inhibitorsPier F Cirillo, Eugene R Hickey, Neil Moss, et al.
Journal of Medicinal Chemistry|October 16, 2004
Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazol-2-one derivativesJiang-Ping Wu, Jonathan Emeigh, Donghong A Gao, et al.
Molecular Carcinogenesis|October 27, 2017
Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancerYun Feng, Yanru Wang, Hongliang Liu, et al.
Journal of Medicinal Chemistry|July 31, 2007
Discovery and optimization of p38 inhibitors via computer-assisted drug designDaniel R Goldberg, Ming-Hong Hao, Kevin C Qian, et al.
Human Molecular Genetics|October 21, 2015
Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactionsDavid C Qian, Jinyoung Byun, Younghun Han, et al.
International Journal of Radiation Oncology, Biology, Physics|April 21, 2021
Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck CancerCanhua Xiao, Andrew H Miller, Gang Peng, et al.
Pageof 36